Valentine Okonkwo
Opinion
[DO NOT PUBLISH]
IN THE UNITED STATES COURT OF APPEALS
FOR THE ELEVENTH CIRCUIT
No. 20-13104
Non-Argument Calendar
D.C. Docket No. 6:19-cv-00638-PGB-GJK
VALENTINE OKONKWO, Petitioner-Appellant,
versus
UNITED STATES OF AMERICA, Respondent-Appellee.
No. 20-13552
Non-Argument Calendar
D.C. Docket No. 6:14-cr-00005-PGB-GJK-1
UNITED STATES OF AMERICA, Plaintiff-Appellee,
versus
VALENTINE OKONKWO, Defendant-Appellant.
Appeals from the United States District Court for the Middle District of Florida
(August 24, 2021)
Before WILLIAM PRYOR, Chief Judge, JILL PRYOR and LUCK, Circuit Judges.
PER CURIAM:
Valentine Okonkwo, a federal prisoner, appeals the denial of his motion to vacate, 28 U.S.C. § 2255, and petition for a writ of audita querela. We issued a certificate of appealability to address whether trial counsel was ineffective for failing to object to the amount of oxycodone attributed to Okonkwo for conspiring to distribute and for distributing that drug illegally. We consolidated that appeal with Okonkwo’s challenge to the denial of his petition for a writ of audita querela to vacate his forfeiture monetary judgment. Because counsel had no obligation to object to Okonkwo being held responsible for all the oxycodone distributed from
his pharmacy and the writ of audita querela was unavailable for him to challenge purported errors that preceded the entry of his forfeiture judgment, we affirm.
I. BACKGROUND
In January 2015, a grand jury returned an amended indictment that charged Okonkwo with conspiring to possess with intent to distribute and ten counts of distributing oxycodone to specific customers outside the usual course of professional practice and for other than a legitimate medical purpose. 21 U.S.C. §§ 846, 841(a)(1), 841(b)(1)(C). The indictment also sought forfeiture of Okonkwo’s pharmaceutical licenses and “a money judgment in the amount of at least $555,000, representing the amount of proceeds [he] obtained . . . from the conspiracy” to distribute oxycodone between December 2009 and October 2012. Id. § 853. Later, the government filed a notice requesting the district court enter a forfeiture monetary judgment against Okonkwo.
Business records and testimony from customers, employees, an owner of an adjacent business, and an expert proved that Okonkwo filled forged, altered, and duplicative prescriptions for oxycodone at his Orlando business, Avalon Park Pharmacy. Emily Bird, an oxycodone addict, testified that Okonkwo filled prescriptions without verification in return for cash payments and advised her to obtain prescriptions of better quality. Three Avalon employees who processed internet and mail-order prescriptions testified that customers often appeared to be
drug addicts and some would lose consciousness at the pharmacy. The owner of a nearby salon observed carloads of customers arrive at Avalon, where they waited outside for hours and become rowdy and intoxicated. A professor of pharmacy practice identified multiple “red flags” in prescriptions Avalon filled, including prescriptions written and submitted on one day for multiple patients by a single doctor and prescriptions dated long before being filled. Business records established that Avalon purchased more oxycodone between 2009 and 2012 than any pharmacy chain store in the area.
Agents of the Drug Enforcement Agency also testified about Avalon’s profits and Okonkwo’s wrongdoing. Agent Paul Short discovered that many prescriptions Avalon filled were written by doctors whose offices were more than 100 miles away, that 74 percent of its transactions involved oxycodone, and that 99 percent of its customers paid with cash, which resulted in proceeds of more than $1.2 million between 2009 and 2012. The agent also learned that Avalon dispensed 563,000 oxycodone tablets between December 2009 and April 2012, which far exceeded the average distribution rate by pharmacies of 72,000 tablets a year and that Okonkwo filled 605 prescriptions and dispensed 120,829 oxycodone tablets. Agent Barbara Boggess discovered that, between 2009 and 2013, Okonkwo underreported to drug distributors the amount of Oxycodone that Avalon sold, cash payments it received, and sales it made to remote customers and that he
misrepresented that Avalon verified prescriptions with physicians and reported fraudulent prescriptions to law enforcement. Agent Deana Diapola testified that she and other agents observed Okonkwo falsely mark forged prescriptions as being verified with issuing physicians.
During trial, the parties disputed the process for obtaining a forfeiture monetary judgment. The prosecutor argued that Federal Rule of Criminal Procedure 32.2(b)(1) and United States v. Curbelo, 726 F.3d 1260 (11th Cir. 2013), dictated that the district court should determine the amount Okonkwo had to pay. Defense counsel argued that the determination of the amount rested with the jury.
The jury found Okonkwo guilty of one count of conspiring to distribute and ten counts of distributing oxycodone without a legitimate medical purpose. The jury also returned a special verdict finding that Okonkwo used his professional licenses to commit his crimes. The district court ordered Okonkwo to forfeit his licenses. Later, the district court granted the motion of the government for a forfeiture monetary judgment against Okonkwo of $555,000.
Okonkwo’s presentence investigation report provided a base offense level of 38 for distributing more than 15 kilograms of oxycodone between December 2009 and April 2012 by dispensing 491,706 30-milligram tablets and 65,217 15- milligram tablets, which equated to 105,387 kilograms of marijuana. United States
Sentencing Guidelines Manual § 2D1.1(c)(1) (Nov. 2015). The presentence report added two levels for Okonkwo’s use of a special skill, id. § 3B1.3, which resulted in a total offense level of 40. With a criminal history category of I, Okonkwo’s presentence report provided an advisory sentencing range of 292 to 365 months of imprisonment. The report stated that Okonkwo was unable to pay a fine due to “pending forfeitures” and other financial obligations.
Okonkwo objected to the use of a 1:6700 ratio of oxycodone to marijuana and argued that the district court should apply a 1:500 ratio, which would result in a base offense level of 32, but the district court overruled his objection. The district court ruled that, despite counsel’s “cogent point” about the equivalency ratio, the sentencing guidelines did not overrepresent the seriousness of Okonkwo’s offense because “oxycodone carrie[d] distinct risks, unlike heroin, due to its legitimate medical use and accessibility” and Okonkwo’s ability to “sell it in plain view of the public with a sense of security.”
The district court recounted the evidence against Okonkwo and sentenced him to 292 months of imprisonment. The district court reminded Okonkwo that it had addressed the “matter of forfeiture . . . [in] a [preliminary] order . . . [and] a final order.” The prosecutor interjected that the orders referenced did not pertain to Okonkwo’s “license . . . [being] forfeited by the jury at trial.” Okonkwo appealed
and challenged his convictions, which we affirmed. United States v. Okonkwo, 702 F. App’x 866 (11th Cir. 2017).
While Okonkwo’s appeal was pending, he moved pro se to reduce the forfeiture monetary judgment from $555,000 to $10,000. Okonkwo argued that appellate counsel told him about the judgment and that it should have equaled the proceeds of his unlawful transactions with the ten customers identified in his indictment. The government responded that Okonkwo received notice of the personal money judgment during his trial and at sentencing, that he failed timely to challenge the judgment, and that it was correctly based on the proceeds of the conspiracy. The district court denied Okonkwo’s motion.
Free access — add to your briefcase to read the full text and ask questions with AI
Valentine Okonkwo (Valentine Okonkwo) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.